Eudaimonia Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $47.5K | Sell |
25,945
-799
| -3% | -$1.46K | 0.01% | 255 |
|
|
2023
Q4 | $33.2K | Sell |
26,744
-400
| -1% | -$496 | 0.01% | 249 |
|
|
2023
Q3 | $30.9K | Hold |
27,144
| – | – | 0.01% | 327 |
|
|
2023
Q2 | $24.8K | Buy |
27,144
+15,000
| +124% | +$13.7K | 0.01% | 344 |
|
|
2023
Q1 | $6.81K | Buy |
+12,144
| New | +$6.81K | ﹤0.01% | 345 |
|
|
2022
Q4 | – | Sell |
-27,144
| Closed | -$9K | – | 343 |
|
|
2022
Q3 | $9K | Hold |
27,144
| – | – | ﹤0.01% | 339 |
|
|
2022
Q2 | $10K | Hold |
27,144
| – | – | ﹤0.01% | 387 |
|
|
2022
Q1 | $19K | Buy |
+27,144
| New | +$19K | ﹤0.01% | 402 |
|